 |
인쇄하기
취소
|
Lilly Korea launches Byetta injections
Lilly Korea has launched Byetta (exenatide), the first in a new class of medications specifically created to treat type 2 diabetes.
Byetta (5 mcg exenatide or 10 mcg exenatide) is indicated as an add-on therapy for use twice a day in adults with type 2 diabetes who are unsuccessful at controlling their blood sugar levels using common oral diabetes medications and comes in a prefilled pen wit...
Byetta (5 mcg exenatide or 10 mcg exenatide) is indicated as an add-on therapy for use twice a day in adults with type 2 diabetes who are unsuccessful at controlling their blood sugar levels using common oral diabetes medications and comes in a prefilled pen wit...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.